Search Site

Trends banner

Oracle shares up 35%

Huge AI contracts lead to the surge.

ADCB to raise $1.66bn

The rights issue aimed at boosting growth.

EGA H1 revenue $4.11bn

Net profit before GAC $445 million.

Borouge to pay $660m H1 dividend

Its net profit for H1 was $474 million.

TAQA secures $2.31bn loan

It will be utilized in a phased manner.

Nvidia tops $4 trillion as US stocks shrug off latest tariffs

Nvidia tops $4 trillion in market capitalization. (AFP)
  • But stocks pushed higher nonetheless, with Nvidia jumping 2.5 percent to top $4 trillion in market capitalization on investor bullishness over Artificial Intelligence (AI) growth.
  • Briefing.com analyst Patrick O'Hare said investors are not "overly concerned" about Trump's latest tariff threats.

New York, United States — Wall Street stocks bounced early Wednesday following two downcast sessions, shrugging off US President Donald Trump’s latest tariff threats as Nvidia surged to a fresh record.

After Congress gave Trump a big win last week with his fiscal package, the Republican’s aggressive trade posture has returned with a vengeance this week.

On Tuesday, he added threatened levies on copper and pharmaceuticals to a laundry list of countries warned of higher tariffs.

But stocks pushed higher nonetheless, with Nvidia jumping 2.5 percent to top $4 trillion in market capitalization on investor bullishness over Artificial Intelligence (AI) growth.

About 30 minutes into trading, the Dow Jones Industrial Average was up 0.5 percent at 44,477.06.

The broad-based S&P 500 advanced 0.7 percent to 6,266.23, while the tech-rich Nasdaq Composite Index rose 1.1 percent to 20,586.42.

Briefing.com analyst Patrick O’Hare said investors are not “overly concerned” about Trump’s latest tariff threats.

“The assumption, it seems, is that better terms with trading partners of economic consequence will get worked out and that the tariffs won’t be as onerous as advertised from a growth or inflation standpoint,” O’Hare wrote in a note.

Among individual companies, Merck rose 2.5 percent after announcing it reached a deal to acquire Verona Pharma, a biopharmaceutical company focused on respiratory diseases for about $10 billion. Verona jumped 20.7 percent.

Later Wednesday, markets will digest minutes from the most recent Federal Reserve meeting, at which central bankers kept interest rates unchanged.